Bevacizumab Side Effects (Avastin, Anti-VEGF) | Medical Algorithm

Are you evaluating a patient being treated with bevacizumab (Avastin)?

Yes

Is the patient also receiving?

• paclitaxel/carboplatin?

Yes

• sunitinib malate?

Yes

Has the patient?

• developed a hemolytic anemia with schistocytes?

Yes

• thrombocytopenia?

Yes

• renal dysfunction associated with a glomerular thrombotic microangiopathy?

Yes

• reversible posterior leukoencephalopathy syndrome?

Yes

Is there another diagnosis that can explain the findings better?

Yes

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Is the patient at increased risk for a hemolytic anemia?

Number of findings seen with micro-angiopathic hemolytic anemia and/or TTP

Number of reasons to suspect another diagnosis

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
Severity, Prognosis, Stage
- Score for Bleeding Following Bone Marrow Transplantation
- Scale for Bleeding Following Therapy for Acute Leukemia
Complications
- Score for Bleeding Following Bone Marrow Transplantation

Monitoring

Response To Therapy
- Scale for Bleeding Following Therapy for Acute Leukemia
Adverse Effects
Complication Detection
- Risk Score of Dranitsaris et al for Predicting Chemotherapy-Induced Anemia in a Woman with for Breast Cancer

Evaluation

Results

Please fill out required fields.

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Monitoring

Specialty

Objective

ICD-10

TTP or MAHA | Bevacizumab (Avastin, Anti-VEGF) Therapy Side Effects

Purpose: To identify thrombotic thrombocytopenic purpura (TTP) or microangiopathic hemolytic anemia in a patient treated with Avastin.

Evaluation

Results

Please fill out required fields.

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Monitoring

Specialty

Objective

ICD-10